compounded semaglutide daily sublingual liquid SkinnyRx | Compounded Sublingual Semaglutide

"Weight loss and changes in nutritional status, common consequences of GLP-1 receptor agonist therapy, are established risk factors for telogen effluvium, a common and typically transient form of non-scarring hair loss, providing a plausible biological mechanism for this association," write the researchers

A Study of Retatrutide (LY3437943) to Assess Cardiovascular Outcomes (TRIUMPH-Outcomes)

Peer Reviewed by Rosie Warwick, BSc (Hons) RD Dietitian Rosie is an HCPC-registered clinical dietitian with experience across both paediatric and adult settings

If you've noticed increased fragility or want personalized recommendations for your hair goals, our team would be happy to help you build a routine tailored to you